Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Orgenesis Inc. is a global biotech company specializing in cell and gene therapies (CGTs) with a focus on autologous treatments. It develops, processes, and commercializes advanced therapies for immuno-oncology, metabolic, regenerative, and antiviral diseases. Utilizing its proprietary Point-of-Care (POCare) platform, the company offers decentralized, automated manufacturing near patients, licensing therapies, and collaborating with research institutes and hospitals worldwide to improve access and reduce costs.
This description was generated via AI from an annual report. Updated about 1 year ago.